Picture of Chimerix logo

CMRX — Chimerix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Chimerix Inc reports results for the quarter ended in September - Earnings Summary

* Chimerix Inc  CMRX.OQ  reported quarterly adjusted
earnings of
$2.75​​ per share for the quarter ended in September. The mean
expectation of six analysts for the quarter was for earnings of
$2.14 per share.
    * Revenue rose 30,325.2% to $32.56 million from a year ago;
analysts expected $219.37 million. 
    * Chimerix Inc's reported EPS for the quarter was $2.75​.
    * The mean earnings estimate of analysts had fallen by
about 12.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Chimerix Inc shares had fallen by 3.6% this quarter and
lost 71.1% so far this year.
    * The company reported quarterly net income of $241.36
million.
    * Wall Street's median 12-month price target for Chimerix
Inc is
$6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 01:38 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      2.14           2.75           Beat
 Jun. 30 2022      -0.24          -0.27          Missed
 Mar. 31 2022      -0.33          -0.28          Beat
 Dec. 31 2021      -0.17          -0.45          Missed

Recent news on Chimerix

See all news